JD Healthcare, a unit of China’s e-commerce giant JD.com (NASDAQ: JD), reported robust financial results for H1 2022, with total revenues reaching RMB 20.2 billion (USD 2.94 billion), up 48.3% year-on-year (YOY). Non-IFRS net profits surged 82.0% YOY to RMB 1.21 billion (USD 176.6 million). As of June 30, 2022, the platform had over 131 million annual active users, with average daily medical consultations exceeding 250,000.
Pharmaceutical Supply Chain Management
JD Healthcare operates 20 JD Logistics pharmaceutical warehouses and over 450 non-pharmaceutical warehouses nationwide. Its self-operated cold chain covers more than 240 cities, and its offline DTP pharmacies span 26 provincial regions. The company launched multiple new drugs, including Pfizer’s Cibinqo (abrocitinib) for atopic dermatitis and Sanofi’s Coplavix (aspirin, clopidogrel) for cardiovascular disease.
Digital Innovation and Partnerships
JD Healthcare has become a key partner for pharmaceutical brands in digital transformation. It collaborated with Qilu Pharma on real-world studies and with Takeda Pharma and Gilead Sciences on innovative payment programs. The company also established clinical trial patient recruitment centers with CROs and drugmakers, hosting over 400 studies by June 30, 2022.
Healthcare Service Ecosystem
JD Healthcare upgraded its “JD Pharmacy single disease care center,” increasing therapy days per user by 62% on average. It introduced pharmacy outpatient services to enhance post-diagnosis management. The firm partnered with Beijing Ditan Hospital and Cangzhou Central Hospital to develop internet hospitals with online payment capabilities.
Consumer-Centric Services
The company launched “expert online,” “ask JD Doctor in a second,” and “night emergency” consultation services, with daily online consultations exceeding 250,000. Its consumer medicine business offers health checkups, genetic testing, and medical aesthetics through in-store and door-to-door services. Over 1,000 service providers have joined, covering 4,000 offline stores in more than 500 cities.-Fineline Info & Tech
